drugset / Trial / NCT01667718
Bismuth Improves the Efficacy of Levofloxacin-containing Triple Therapy for Helicobacter Pylori Treatment
RandomizedParallel-groupOpen-labelTreatment
Summary
To examine and compare the efficacy of 2 week Levofloxacin-containing therapies with and without Bismuth for H.pylori treatment.
Timeline
- Start
- 2012-05
- Primary completion
- 2012-10
- Completion
- 2012-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bismuth Potassium Citrate | Unknown | 220 mg | — |
| Background | Amoxicillin | Other / unclassified | 1 g | — |
| Background | Lansoprazole | Other / unclassified | 30 mg | — |
| Background | Levofloxacin | Small molecule | 0.5 unknown | — |